Lipocine News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Lipocine Inc LPCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0309 3.37% 0.9479 11:42:43
Open Price Low Price High Price Close Price Prev Close
0.9098 0.9021 0.9596 0.917
more quote information »

Recent News

Date Time Source Heading
1/25/20228:00IHNWFeaturedQuantum eMotion Announces Acceptance of Its First-Generation Patent in China
1/25/20227:30IHNWFeaturedAmerican Green, Inc. ™ (OTC:ERBB) CBD Water with Vessl ® Cap Technology launched on eBay Groupon and AmericanGreenCBD.com
1/21/202216:01EDGARCurrent Report Filing (8-k)
1/14/202217:14EDGARCurrent Report Filing (8-k)
1/05/202208:00PRNUSLipocine to Present Clinical Data on LPCN 1144 at 2022..
1/04/202208:01EDGARCurrent Report Filing (8-k)
12/22/202111:22EDGARCurrent Report Filing (8-k)
12/22/202109:05SEEKDosing underway in Lipocine's mid-stage LPCN 1148 study for..
12/08/202116:01EDGARStatement of Changes in Beneficial Ownership (4)
12/08/202116:01EDGARStatement of Changes in Beneficial Ownership (4)
11/10/202108:09SEEKLipocine EPS beats by $0.01
11/10/202108:04EDGARCurrent Report Filing (8-k)
11/10/202108:01EDGARQuarterly Report (10-q)
11/10/202108:00PRNUSLipocine Announces Financial Results for the Third Quarter..
11/09/202108:01EDGARCurrent Report Filing (8-k)
11/04/202108:29SEEKLipocine shares jump 9% after FDA Fast Track status for LPCN..
11/04/202108:01EDGARCurrent Report Filing (8-k)
11/04/202108:00PRNUSLipocine Announces FDA Grants Fast Track Designation to LPCN..
11/01/202117:26EDGARCurrent Report Filing (8-k)
11/01/202108:01EDGARCurrent Report Filing (8-k)
11/01/202108:00PRNUSLipocine Announces Multiple Poster Presentations at the..
10/18/202108:15SEEKFCEL, INFI and SIOX among pre market gainers
10/18/202107:01EDGARCurrent Report Filing (8-k)
10/18/202107:00PRNUSLipocine And Antares Pharma Enter Into U.S. Licensing..
10/12/202115:32EDGARCurrent Report Filing (8-k)
10/05/202108:00PRNUSLipocine to Present at The H.C. Wainwright 5th Annual NASH..
9/28/202108:01EDGARCurrent Report Filing (8-k)
9/28/202108:00PRNUSLipocine Announces FDA Affirmation Of Class 1 NDA..
9/20/202108:00PRNUSLipocine to Present at The Cantor Fitzgerald Virtual Global..
9/13/202108:02EDGARCurrent Report Filing (8-k)
9/10/202117:02EDGARCurrent Report Filing (8-k)
9/01/202108:00PRNUSLipocine to Present at The H.C. Wainwright 23rd Annual..
8/25/202106:36EDGARCurrent Report Filing (8-k)
8/25/202106:30PRNUSLipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis..
8/05/202109:05SEEKLipocine EPS misses by $0.03
8/05/202108:02EDGARQuarterly Report (10-q)
8/05/202108:00PRNUSLipocine Announces Financial Results for the Second Quarter..
7/15/202109:00GLOBEClarus Therapeutics Announces Comprehensive Settlement of..
7/14/202116:47SEEKLipocine enters settlement and license agreement with Clarus..
7/14/202116:00PRNUSLipocine Announces Settlement With Clarus Therapeutics
7/06/202108:00PRNUSLipocine To Present At The Ladenburg Thalmann Healthcare..
6/24/202111:08SEEKCantor initiates Lipocine with an overweight rating, sees..
6/23/202108:02EDGARCurrent Report Filing (8-k)
6/23/202108:00PRNUSLipocine Announces Presentations at The International Liver..
6/16/202108:00PRNUSLipocine To Present At The Raymond James Human Health..
6/14/202108:25SEEKLipocine soars 9% on FDA greenlight for Phase 2 LPCN 1154..
6/14/202108:02EDGARCurrent Report Filing (8-k)
6/14/202108:01EDGARCurrent Report Filing (8-k)
6/14/202108:00PRNUSFDA Clears LPCN 1154 IND Application for a Phase 2..
6/10/202114:44EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202114:44EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.